Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
709 (USA) · Dr. Novak
consented 2013-01-26
Adverse events
Mild BENIGN PROSTATIC HYPERPLASIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-17 (study day 51.0); relationship: NONE; serious criteria: hospitalization
Severe BENIGN PROSTATIC HYPERPLASIA — outcome: RECOVERED/RESOLVED; onset 2013-03-17 (study day 51.0); relationship: NONE; serious criteria: hospitalization
Mild BLOOD URINE PRESENT — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-14 (study day 48.0); relationship: NONE
Mild CYSTOSCOPY — outcome: RECOVERED/RESOLVED; onset 2013-03-17 (study day 51.0); relationship: NONE
Mild DEHYDRATION — outcome: RECOVERED/RESOLVED; onset 2013-04-13 (study day 78.0); relationship: NONE
Mild HYPOTENSION — outcome: RECOVERED/RESOLVED; onset 2013-04-13 (study day 78.0); relationship: POSSIBLE; serious criteria: hospitalization
Mild LOCALISED INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-05 (study day 11.0); relationship: NONE
Mild LOCALISED INFECTION — outcome: RECOVERED/RESOLVED; onset 2013-02-05 (study day 11.0); relationship: NONE
Mild ORTHOSTATIC HYPOTENSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-20 (study day 85.0); relationship: POSSIBLE
Mild ORTHOSTATIC HYPOTENSION — outcome: RECOVERED/RESOLVED; onset 2013-04-20 (study day 85.0); relationship: POSSIBLE
Mild PYREXIA — outcome: RECOVERED/RESOLVED; onset 2013-04-13 (study day 78.0); relationship: NONE
Data queries
No data queries.